Home > Insider Trading > Filing (0001127602-20-010517)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
882095	Gilead Sciences Inc	GILD	Biological Products, (No Disgnostic Substances) (2836)	943047598

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1739307	A Brett Pletcher	333 Lakeside Drive Foster City CA 94404	Evp,Corp Affairs & Gen Counsel	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-03-10	2,950	$24.30	17,594	No	4	M	Direct
Common Stock	Disposition	2020-03-10	2,950	$75.55	14,644	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-qualified Stock Option (Right to Buy)	Disposition	2020-03-10	2,950	$0.00	2,950	$24.30
Common Stock	Non-qualified Stock Option (Right to Buy)	Acquisiton	2020-03-10	61,590	$0.00	61,590	$72.34
Common Stock	Restricted Stock Unit	Acquisiton	2020-03-10	10,370	$0.00	10,370	$0.00

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
650	2022-01-26	No	4	M	Direct
61,590	2030-03-10	No	4	A	Direct
18,552		No	4	A	Direct

Footnotes

The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
The shares subject to the option have a four year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
The restricted stock units have a four year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested.